Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Am J Obstet Gynecol. 2017 Dec;217(6):711-712. doi: 10.1016/j.ajog.2017.08.113. Epub 2017 Sep 6.

Authors

Sara De Carolis¹, Francesca Rizzo², Sara Tabacco³

Affiliations

¹ Department of Obstetrics, Gynecology, and Pediatrics, Catholic University of Sacred Heart, Largo Agostino Gemelli 1, Rome RM 00168, Italy. Electronic address: saradecarolis@libero.it.
² Department of Obstetrics, Gynecology, and Pediatrics, Catholic University of Sacred Heart, Largo Agostino Gemelli 1, Rome RM 00168, Italy.
³ Department of Gynecology Obstetrics and Urology, Sapienza University of Rome, Piazzale Aldo Moro, 5, RM 00185 Rome, Italy.

PMID: 28888582
DOI: 10.1016/j.ajog.2017.08.113

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Antiphospholipid*
Antiphospholipid Syndrome
Female
Humans
Hydroxychloroquine*
Pregnancy

Substances

Antibodies, Antiphospholipid
Hydroxychloroquine